 Triiodothyronine treatment Raynaud phenomenon controlled trial effects micrograms triiodothyronine placebo double blind trial patients Raynaud phenomenon Reductions frequency duration severity attacks gradual significant subjects skin ulcer healing Skin hands skin temperature recovery times cold exposure therapy placebo large dosages patients experienced episodic palpitations slight significant increases heart rate pulse pressure Evaluation use physiological doses micrograms treatment Raynaud phenomenon